OMERS Administration Corp’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.5M | Buy |
56,160
+10,169
| +22% | +$838K | 0.03% | 269 |
|
|
2025
Q4 | $3.92M | Buy |
45,991
+1,487
| +3% | +$122K | 0.03% | 227 |
|
|
2025
Q3 | $3.46M | Hold |
44,504
| – | – | 0.02% | 247 |
|
|
2025
Q2 | $3.48M | Buy |
44,504
+21,950
| +97% | +$1.64M | 0.03% | 215 |
|
|
2025
Q1 | $1.63M | Sell |
22,554
-110,846
| -83% | -$7.93M | 0.01% | 445 |
|
|
2024
Q4 | $9.88M | Buy |
133,400
+3,481
| +3% | +$244K | 0.09% | 106 |
|
|
2024
Q3 | $8.57M | Sell |
129,919
-24,000
| -16% | -$1.74M | 0.08% | 119 |
|
|
2024
Q2 | $14.2M | Buy |
153,919
+23,773
| +18% | +$2.11M | 0.14% | 74 |
|
|
2024
Q1 | $12.4M | Sell |
130,146
-4,140
| -3% | -$348K | 0.14% | 61 |
|
|
2023
Q4 | $10.2M | Buy |
134,286
+31,094
| +30% | +$2.16M | 0.13% | 69 |
|
|
2023
Q3 | $7.15M | Buy |
103,192
+49,478
| +92% | +$3.98M | 0.11% | 70 |
|
|
2023
Q2 | $5.07M | Hold |
53,714
| – | – | 0.08% | 77 |
|
|
2023
Q1 | $4.44M | Sell |
53,714
-8,821
| -14% | -$693K | 0.07% | 80 |
|
|
2022
Q4 | $4.67M | Buy |
62,535
+27,169
| +77% | +$2.09M | 0.07% | 73 |
|
|
2022
Q3 | $2.92M | Hold |
35,366
| – | – | 0.05% | 84 |
|
|
2022
Q2 | $3.36M | Buy |
+35,366
| New | +$3.66M | 0.05% | 86 |
|
|
2021
Q4 | – | Sell |
-51,859
| Closed | -$5.87M | – | 412 |
|
|
2021
Q3 | $5.87M | Buy |
+51,859
| New | +$5.92M | 0.09% | 65 |
|
|
2021
Q2 | – | Sell |
-45,098
| Closed | -$3.77M | – | 41 |
|
|
2021
Q1 | $3.77M | Buy |
45,098
+4,052
| +10% | +$343K | 0.06% | 69 |
|
|
2020
Q4 | $3.75M | Buy |
+41,046
| New | +$3.4M | 0.07% | 84 |
|
|
2020
Q1 | – | Sell |
-128,400
| Closed | -$9.98M | – | 255 |
|
|
2019
Q4 | $9.98M | Sell |
128,400
-4,800
| -4% | -$375K | 0.12% | 99 |
|
|
2019
Q3 | $9.76M | Buy |
133,200
+10,200
| +8% | +$717K | 0.1% | 105 |
|
|
2019
Q2 | $7.68M | Buy |
123,000
+7,500
| +6% | +$454K | 0.08% | 129 |
|
|
2019
Q1 | $7.63M | Buy |
+115,500
| New | +$6.59M | 0.09% | 72 |
|
|
2016
Q4 | – | Sell |
-163,500
| Closed | -$6.57M | – | 397 |
|
|
2016
Q3 | $6.57M | Buy |
163,500
+57,900
| +55% | +$2.18M | 0.12% | 118 |
|
|
2016
Q2 | $3.51M | Sell |
105,600
-21,300
| -17% | -$729K | 0.07% | 170 |
|
|
2016
Q1 | $3.73M | Sell |
126,900
-47,100
| -27% | -$1.3M | 0.08% | 154 |
|
|
2015
Q4 | $4.58M | Sell |
174,000
-65,400
| -27% | -$1.7M | 0.12% | 140 |
|
|
2015
Q3 | $5.67M | Buy |
239,400
+4,200
| +2% | +$101K | 0.17% | 120 |
|
|
2015
Q2 | $5.58M | Buy |
+235,200
| New | +$5.31M | 0.22% | 112 |
|
Other funds holding EW
VCM
VPM
OMERS Administration Corp's EW Position: Q1 2026 in Review
OMERS Administration Corp increased its Edwards Lifesciences (EW) stake by 22% in Q1 2026, buying an estimated $838K and bringing the position to 56,160 shares worth $4.5M. The position accounts for 0.03% of the portfolio, ranked #269.
OMERS Administration Corp first reported a position in EW in Q2 2015 and has held it in 29 quarters since. The position peaked at $14.2M in Q2 2024. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- OMERS Administration Corp held 56,160 shares of Edwards Lifesciences worth $4.5M as of Q1 2026.
- OMERS Administration Corp bought 10,169 Edwards Lifesciences shares in Q1 2026, an estimated $838K.
- Edwards Lifesciences made up 0.03% of OMERS Administration Corp's portfolio in Q1 2026, its #269 holding.
- OMERS Administration Corp first reported a position in Edwards Lifesciences in Q2 2015 and has held it in 29 quarters since.
- OMERS Administration Corp's Edwards Lifesciences position peaked at $14.2M in Q2 2024.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.